Kurs
+4,78%
Likviditet
8,39 MNOK
Kalender
| Tid* | ||
| 2026-02-19 | 08:00 | Bokslutskommuniké 2025 |
| 2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-26 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-13 | N/A | Årsstämma |
| 2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-20 | 08:00 | Bokslutskommuniké 2024 |
| 2024-11-20 | - | Extra Bolagsstämma 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-15 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2024-05-14 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-02 | - | X-dag halvårsutdelning CONTX 0.15741 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag halvårsutdelning CONTX 0.15741 |
| 2023-05-05 | - | X-dag halvårsutdelning CONTX 0.15645 |
| 2023-05-03 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-20 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-11 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-05 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2022-05-04 | - | Årsstämma |
| 2022-04-21 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-12-10 | - | Extra Bolagsstämma 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Split CONTX 1:10 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-08-05 | - | Extra Bolagsstämma 2020 |
| 2020-05-07 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2020-05-06 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2019-05-08 | - | Årsstämma |
| 2019-04-25 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-21 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2018-05-09 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-10-26 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2017-05-10 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-18 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-21 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-21 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2016-04-20 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-20 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-23 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-23 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2015-04-22 | - | Årsstämma |
| 2015-02-19 | - | Bokslutskommuniké 2014 |
| 2014-10-23 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-12 | - | 15-7 2014 |
| 2014-04-24 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-24 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2014-04-23 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-10-24 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2013-06-12 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-21 | - | Bokslutskommuniké 2012 |
| 2012-10-25 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-23 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-14 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2012-06-13 | - | Årsstämma |
| 2012-04-26 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-23 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-25 | - | Kvartalsrapport 2011-Q2 |
| 2011-06-10 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2011-06-09 | - | Årsstämma |
| 2011-04-28 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-10-21 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-06-04 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2010-06-03 | - | Årsstämma |
| 2010-04-21 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-18 | - | Bokslutskommuniké 2009 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-20 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-23 | - | Kvartalsrapport 2009-Q1 |
| 2008-06-06 | - | X-dag ordinarie utdelning CONTX 1.50 NOK |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.
Stockholm, Dec 18, 2024
Reference is made to the stock exchange announcement on December 13th, 2024, in which ContextVision AB (publ) ("ContextVision" or the "Company") launched an offer to buy back up to 3,000,000 shares in the Company for a total amount of up to NOK 15,000,000 (the "Offer").
The application period for the Offer ended on December 17th, 2024 at 16:30 CET. Following the end of the application period, the Company has resolved to buy back 1,205,735 shares in the Company at a price of NOK 6.50 per share, amounting to a total of NOK 7,837,277.50.
All offers to sell shares with limits at or below NOK 6.50 have been fully allocated.
Allocation notifications are expected to be sent to the shareholders who tendered shares in the Offer on or about December 18th, 2024. The trade date is expected to be on or about 18 December 2024 with the settlement date expected on or about December 20th, 2024.
The settlement will be conducted on a normal delivery-versus-payment basis. Following the settlement of the Offer, the Company will own 1,205,735 shares in the Company. The Company currently has 77,367,500 shares outstanding.
This stock exchange announcement is published in accordance with the disclosure requirements in Section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Richard Hallström, CFO, on the time and date provided.
For more information, please contact:
Carnegie AS: contextvision@carnegie.no or +47 22 00 93 40
Richard Hallström, CFO: richard.hallstrom@contextvision.com
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X -ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.